# P944: REAL-WORLD PATIENT CHARACTERISTICS AND SURVIVAL OUTCOMES OF LENALIDOMIDE REFRACTORY VS. LENALIDOMIDE EXPOSED RRMM PATIENTS IN THE HONEUR FEDERATED DATA NETWORK

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p944-real-world-patient-characteristics-and-survival-outcomes-of-lenalidomide/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ivan Špıčka,Ido Lapidot,Maximilian Merz,Jakub Radocha,Martin Štork,Tomáš Jelı́nek,Alexandra Jungová,Jiří Minařík,J. Soukup,Michel van Speybroeck,Nolen Joy Perualila,Joris Diels,João Duarte Mendes,Kirsten van Nimwegen,Kai Strobel,S Wischlen,Henrik Sliwka,Blanca Gros Otero,Roman Hájek |
| Citations | 2 |
| DOI | 10.1097/01.hs9.0000970680.25812.6d |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://dx.doi.org/10.1097/01.hs9.0000970680.25812.6d |
| OpenAlex ID | https://openalex.org/W4385667113 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Kirsten van Nimwegen](https://scholariq.org/researchers/kirsten-van-nimwegen/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.